{
"id":"mk19_bb_pm_s3",
"subspecialtyId":"pm",
"title":"Chronic Obstructive Pulmonary Disease",
"jsonContent":{
"type":"section",
"id":"mk19_bb_pm_s3",
"title":{
"__html":"Chronic Obstructive Pulmonary Disease"
},
"titleNode":{
"type":"section-title",
"hlId":"dffff5",
"children":[
"Chronic Obstructive Pulmonary Disease"
]
},
"children":[
{
"type":"section",
"id":"mk19_bb_pm_s3_1",
"title":{
"__html":"Screening"
},
"titleNode":{
"type":"section-title",
"hlId":"db7551",
"children":[
"Screening"
]
},
"children":[
{
"type":"p",
"hlId":"3f19a7",
"children":[
"Screening asymptomatic patients for ",
{
"type":"abbreviation",
"title":"chronic obstructive pulmonary disease",
"children":[
"COPD"
]
},
" is not recommended by the ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"U.S. Preventive Services Task Force",
"children":[
"USPSTF"
]
},
"."
]
}
]
}
]
},
{
"type":"section",
"id":"mk19_bb_pm_s3_2",
"title":{
"__html":"Diagnosis"
},
"titleNode":{
"type":"section-title",
"hlId":"523223",
"children":[
"Diagnosis"
]
},
"children":[
{
"type":"p",
"hlId":"538352",
"children":[
"COPD is a heterogeneous disorder that includes emphysema, chronic bronchitis, obliterative bronchiolitis, and asthmatic bronchitis. Patients typically present with cough, sputum production, dyspnea, and decreased exercise tolerance and energy level. The features most predictive of COPD in a symptomatic patient are the combination of:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"c4e78a",
"children":[
"smoking history"
]
},
" ",
{
"type":"list-item",
"hlId":"9fa333",
"children":[
"wheezing on auscultation"
]
},
" ",
{
"type":"list-item",
"hlId":"cf07d6",
"children":[
"self-reported wheezing"
]
},
" "
]
},
{
"type":"p",
"hlId":"5de86e",
"children":[
"Diagnose COPD when postbronchodilator spirometry shows an ",
{
"type":"abbreviation",
"title":"forced expiratory volume exhaled in 1 second",
"children":[
"FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
}
]
},
"/",
{
"type":"abbreviation",
"title":"forced vital capacity",
"children":[
"FVC"
]
},
" ratio <0.7 (or below ",
{
"type":"abbreviation",
"title":"lower limit of normal",
"children":[
"LLN"
]
},
") associated with symptoms of chronic bronchitis, emphysema, or both."
]
},
{
"type":"p",
"hlId":"e576a2",
"children":[
"Measure ",
{
"type":"abbreviation",
"title":"α1-antitrypsin",
"children":[
"AAT"
]
},
" level in all patients with COPD."
]
},
{
"type":"inline-wrap",
"wrapId":"1",
"contentIds":[
"mk19_bb_pm_s3_inline_t1"
],
"forceOpen":true
}
]
},
{
"type":"section",
"id":"mk19_bb_pm_s3_3",
"title":{
"__html":"Treatment"
},
"titleNode":{
"type":"section-title",
"hlId":"4c4ac0",
"children":[
"Treatment"
]
},
"children":[
{
"type":"p",
"hlId":"944487",
"children":[
"Smoking cessation is essential in the management of all patients with COPD to reduce the rate of decline in lung function."
]
},
{
"type":"p",
"hlId":"1f5ae2",
"children":[
"Many classification schemes help guide pharmacologic therapy of COPD, based on symptoms, number of exacerbations, and spirometry results."
]
},
{
"type":"p",
"hlId":"efbee3",
"children":[
"Strong evidence-based recommendations:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"737095",
"children":[
"For symptomatic patients with COPD and FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" <60% of predicted, monotherapy using long-acting anticholinergic agents (",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"long-acting muscarinic agent (also called longacting anticholinergic agent)",
"children":[
"LAMA"
]
},
"s"
]
},
" or ",
{
"type":"abbreviation",
"title":"long-acting β2-agonist",
"children":[
"LABA"
]
},
"s) is recommended."
]
},
" ",
{
"type":"list-item",
"hlId":"f5e361",
"children":[
"For symptomatic patients with an FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" <50% of predicted, pulmonary rehabilitation is recommended."
]
},
" ",
{
"type":"list-item",
"hlId":"52f4a3",
"children":[
"Pulmonary rehabilitation is recommended following hospitalization for a COPD exacerbation."
]
},
" ",
{
"type":"list-item",
"hlId":"b3c119",
"children":[
"For patients with COPD who have severe resting hypoxemia (arterial P",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" <55 mm Hg or O",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" saturation <88%), continuous oxygen therapy is recommended."
]
},
" "
]
},
{
"type":"p",
"hlId":"fbeb7e",
"children":[
"Weaker evidence-based recommendations:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"5a6c6f",
"children":[
"For stable patients with COPD with respiratory symptoms and FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" between 60% and 80% of predicted, inhaled bronchodilators may be used."
]
},
" ",
{
"type":"list-item",
"hlId":"91e890",
"children":[
"For symptomatic patients with stable COPD and FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" <60% of predicted, combination inhaled therapies (LAMAs, LABAs, or inhaled glucocorticoids) may be considered."
]
},
" ",
{
"type":"list-item",
"hlId":"7d2a6f",
"children":[
"For symptomatic or exercise-limited patients with an FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" >50% of predicted, pulmonary rehabilitation may be considered."
]
},
" "
]
},
{
"type":"p",
"hlId":"c5f1a4",
"children":[
"An additional indication for which long-term oxygen therapy should be considered is an arterial blood P",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"O"
]
},
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"2"
]
},
" ≤59 mm Hg with signs of tissue hypoxia (polycythemia, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"pulmonary hypertension",
"children":[
"PH"
]
},
","
]
},
" right-sided ",
{
"type":"abbreviation",
"title":"heart failure",
"children":[
"HF"
]
},
")"
]
},
{
"type":"p",
"hlId":"5282d5",
"children":[
"Other therapies for stable COPD:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"4c1bcd",
"children":[
{
"type":"abbreviation",
"title":"phosphodiesterase type 4",
"children":[
"PDE-4"
]
},
" inhibitor (roflumilast) as add-on therapy for severe COPD (bronchitis variant) to prevent recurrent exacerbations"
]
},
" ",
{
"type":"list-item",
"hlId":"3f9ec8",
"children":[
"long-term macrolide therapy (bronchitis variant) to prevent recurrent exacerbations"
]
},
" ",
{
"type":"list-item",
"hlId":"700c64",
"children":[
"nocturnal noninvasive mechanical ventilation to improve oxygenation, improve sleep, and decrease daytime somnolence in patients with chronic hypercapnia"
]
},
" ",
{
"type":"list-item",
"hlId":"d3ed88",
"children":[
"palliative use of oral or parenteral opioids in patients with severe COPD and unremitting dyspnea at end of life"
]
},
" ",
{
"type":"list-item",
"hlId":"d0b944",
"children":[
"pneumococcal and COVID-19 vaccinations and annual influenza immunization"
]
},
" ",
{
"type":"list-item",
"hlId":"822ef6",
"children":[
"consideration of lung volume reduction surgery for patients with upper lobe emphysema (heterogeneous disease) and low baseline exercise capacity to improve mortality, exercise capacity, and quality of life"
]
},
" ",
{
"type":"list-item",
"hlId":"28dc56",
"children":[
"lung transplantation (can increase quality of life and functional capacity in select patients)"
]
},
" ",
{
"type":"list-item",
"hlId":"6371cd",
"children":[
"augmentation therapy with IV human AAT for patients with severe AAT deficiency, AAT activity level <11 μm, and FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" <65%"
]
},
" "
]
},
{
"type":"p",
"hlId":"895f4b",
"children":[
"Antibiotics, glucocorticoids, oxygen supplementation, and noninvasive ventilation are indicated for exacerbations of COPD defined by increased sputum production, purulent sputum, and worsening dyspnea. Consider:"
]
},
{
"type":"list",
"children":[
" ",
{
"type":"list-item",
"hlId":"2da7db",
"children":[
"antibiotics: macrolide, tetracycline, β-lactam/β-lactamase inhibitor"
]
},
" ",
{
"type":"list-item",
"hlId":"603d27",
"children":[
"prednisone, 40 mg for 5-7 days"
]
},
" ",
{
"type":"list-item",
"hlId":"2a3cbf",
"children":[
"increased dose/frequency of bronchodilators; combined ",
{
"type":"abbreviation",
"title":"short-acting β2-agonist",
"children":[
"SABA"
]
},
" and short-acting muscarinic antagonist"
]
},
" ",
{
"type":"list-item",
"hlId":"88b61e",
"children":[
"noninvasive ventilation for acute hypercapnic respiratory failure with acidosis (unless patient is obtunded, vomiting, or has excessive secretions)"
]
},
" ",
{
"type":"list-item",
"hlId":"e92a2e",
"children":[
"invasive mechanical ventilation if not responding or is not a candidate for noninvasive ventilation (see Invasive Mechanical Ventilation)"
]
},
" ",
{
"type":"list-item",
"hlId":"2d2a4d",
"children":[
"pulmonary rehabilitation following hospital discharge"
]
},
" "
]
}
]
},
{
"type":"section",
"id":"mk19_bb_pm_s3_4",
"title":{
"__html":"Test Yourself"
},
"titleNode":{
"type":"section-title",
"hlId":"7866cc",
"children":[
"Test Yourself"
]
},
"children":[
{
"type":"p",
"hlId":"48011c",
"class":"test",
"children":[
"A 55-year-old man is evaluated for progressive dyspnea. He has a 40-pack-year cigarette smoking history. On spirometry, his FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" is 54% of predicted. He is using an albuterol inhaler with increasing frequency. Therapy is prescribed."
]
},
{
"type":"p",
"hlId":"561ea8",
"class":"test_answer",
"children":[
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Answer:"
]
},
" ",
"For management, choose a LAMA or LABA."
]
},
{
"type":"heading",
"class":"tricked",
"children":[
"Don't Be Tricked"
]
},
{
"type":"list",
"class":"tricked",
"children":[
" ",
{
"type":"list-item",
"hlId":"a5e6d1",
"children":[
"Do not use short-acting and long-acting anticholinergic agents together."
]
},
" ",
{
"type":"list-item",
"hlId":"c20d65",
"children":[
"Do not use theophylline."
]
},
" ",
{
"type":"list-item",
"hlId":"48a687",
"children":[
"PDE-4 inhibitors are not indicated for acute bronchospasm."
]
},
" ",
{
"type":"list-item",
"hlId":"258906",
"children":[
"Lung volume reduction therapy is not indicated for patients with an FEV",
{
"type":"tag",
"tagName":"sub",
"attrs":{
},
"children":[
"1"
]
},
" <20% of predicted or a ",
{
"type":"abbreviation",
"title":"diffusing capacity of lung for carbon monoxide",
"children":[
"D",
{
"type":"tag",
"tagName":"small",
"attrs":{
},
"children":[
"LCO"
]
}
]
},
" <20% of predicted."
]
},
" "
]
}
]
}
]
},
"tablesContent":{
"mk19_bb_pm_s3_inline_t1":{
"id":"mk19_bb_pm_s3_inline_t1",
"number":1,
"bookId":"pm",
"title":{
"__html":"Study Table: Mimics of COPD"
},
"jsonContent":{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"e74c82",
"children":[
"Study Table: Mimics of COPD"
]
}
]
},
{
"type":"tag",
"tagName":"thead",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"e7067a",
"class":"col hd l",
"children":[
"Disease"
]
},
" "
]
},
{
"type":"tag",
"tagName":"th",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"93932b",
"class":"col hd l",
"children":[
"Characteristics"
]
},
" "
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"c119ec",
"class":"cell txt l",
"children":[
"Bronchiectasis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"8c3113",
"class":"cell txt l",
"children":[
"Often secondary to an inciting event, such as childhood pneumonia or ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"tuberculosis",
"children":[
"TB"
]
},
";"
]
},
" may be associated with foreign body, ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"cystic fibrosis",
"children":[
"CF"
]
},
","
]
},
" immotile ciliary syndrome, nontuberculous mycobacteria, and allergic bronchopulmonary aspergillosis"
]
},
" ",
{
"type":"p",
"hlId":"fcfdb3",
"class":"cell txt l",
"children":[
"Large-volume sputum production with purulent exacerbations; hemoptysis"
]
},
" ",
{
"type":"p",
"hlId":"d96fb6",
"class":"cell txt l",
"children":[
"Chest x-ray showing “tram lines”; diagnose with ",
{
"type":"no-wrap",
"children":[
{
"type":"abbreviation",
"title":"high-resolution computed tomography",
"children":[
"HRCT"
]
},
","
]
},
" which will show airway diameter greater than that of its accompanying vessel and lack of distal airway tapering"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"281637",
"class":"cell txt l",
"children":[
"Cystic fibrosis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"6ce983",
"class":"cell txt l",
"children":[
"Obstructive pulmonary disease (ultimately with bronchiectasis) or ",
{
"type":"abbreviation",
"title":"gastrointestinal",
"children":[
"GI"
]
},
" symptoms are the most common presentation in adult patients; other symptoms may include recurrent respiratory infections and infertility"
]
},
" ",
{
"type":"p",
"hlId":"9b82f2",
"class":"cell txt l",
"children":[
"Positive sweat chloride test result"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"5a1982",
"class":"cell txt l",
"children":[
"Adult bronchiolitis"
]
},
" "
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"rowSpan":"1",
"colSpan":"1"
},
"children":[
" ",
{
"type":"p",
"hlId":"0bad5e",
"class":"cell txt l",
"children":[
"Found in current or former smokers; may be idiopathic or associated with other diseases such as ",
{
"type":"abbreviation",
"title":"rheumatoid arthritis",
"children":[
"RA"
]
}
]
},
" ",
{
"type":"p",
"hlId":"c17893",
"class":"cell txt l",
"children":[
"Poorly responsive to bronchodilators; may respond to smoking cessation and glucocorticoids"
]
},
" "
]
}
]
}
]
}
]
},
"footnotes":[

]
}
}
}